Designing Anti-USAG-1 Neutralizing Antibody Formulation Using Controlled Drug Delivery Targeting Specific Teeth: A Review

Author(s)	DR. MOHAMMED SIRAJUDDIN KHAN, NIRLIPTA SWAI
Country	India
Abstract	The development of controlled drug delivery systems for anti-USAG-1 (uterine sensitization-associated gene-1) neutralizing antibodies has opened new avenues in targeted therapeutic interventions. This approach is particularly impactful in dental applications, where localized delivery to specific teeth can enhance treatment outcomes while minimizing systemic side effects. This review explores the mechanisms of action of anti-USAG-1 antibodies, advancements in controlled drug delivery systems, and their application in tooth-specific therapies. Challenges and future directions in optimizing these formulations are also discussed.
Field	Medical / Pharmacy
Published In	Volume 16, Issue 1, January-March 2025
Published On	2025-01-13
DOI	https://doi.org/10.71097/IJSAT.v16.i1.1416
Short DOI	https://doi.org/g82pb5

About IJSAT Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us	Message on WhatsApp	+91-9687-182-185	editor@ijsat.org

International Journal on Science and Technology